No Detail Found!

Reversal reaction in a borderline lepromatous leprosy patient after COVID-19 vaccine: Prevention or risks?

Author(s)
Rusmawardiana Department of Dermatology and and Venereology, Faculty of Medicine Sriwijaya University, Dr. Mohammad Hoesin General Hospital, Palembang, South Sumatra, Indonesia.
Fifa Argentina Department of Dermatology and and Venereology, Faculty of Medicine Sriwijaya University, Dr. Mohammad Hoesin General Hospital, Palembang, South Sumatra, Indonesia.
Raden Pamudji Department of Dermatology and and Venereology, Faculty of Medicine Sriwijaya University, Dr. Mohammad Hoesin General Hospital, Palembang, South Sumatra, Indonesia.
Odelia Jovita Jusuf Fantoni Department of Dermatology and and Venereology, Faculty of Medicine Sriwijaya University, Dr. Mohammad Hoesin General Hospital, Palembang, South Sumatra, Indonesia.
Abstract
Reversal reaction in leprosy is an immunologically mediated response due to alteration of cellmediated immunity associated in leprosy spectrum. In COVID-19 pandemic era, leprosy patient is susceptible to the infection. According to guideline, vaccination should be given to leprosy patients. This case reported a 33-year-old male with reversal reaction after COVID-19 vaccination. On examination, patient had erythematous plaque of the face, trunk and extremities, also multiple ulcers of the trunk and extremities. Treatment was commenced immediately with prednisone and second vaccination was delayed. Within our follow-up, marked improvement were obtained after 6 weeks.
Publication Details
Page(s) 609-612
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 32, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
borderline lepromatous leprosy, Reversal reaction
0

Citations

0

Downloads

23

Views